The Life Sciences Report Interview With MYOS Chairman Robert J. Hariri

In a recent interview with George S. Mack of The Life Sciences Report, MYOS Executive Chairman Robert J. Hariri describes how his businesses address some of the great unmet needs in medicine. Hariri also discusses the special nature and advantages of placenta-derived stem cells, and an elegant solution to the scourge of muscle wasting in late-stage disease and advancing age that could apply to treatment of cardiovascular disease in the future. To read the full interview, click here.